Work

Abstract CT164: Efficacy and safety of osimertinib therapy in high-risk stage I EGFRm NSCLC after R0 resection(OSTAR): A phase II, prospective, single-arm study

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct164

Authors: Jiping Xie, Chen Chen, Bin Zhang, Changli Wang, Qiang Zhang, Zhenfa Zhang, Lei Zhang, Shengguang Wang, Xinyue Wang, Richeng Jiang, Dongsheng Yue

Institution: Tianjin Medical University Cancer Institute and Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822090

Cites:

Cited by: 1

Related to: 10